News
Zacks Small Cap Research on MSN13h
COCP: Topline Results for High-Dose Cohort from Phase 1 Trial of CDI-988 Expected in 2Q25…COCP READ THE FULL COCP RESEARCH REPORT Business Update Update on CDI-988 In January 2025, Cocrystal Pharma, Inc. (NASDAQ:COCP) announced results from the Phase 1 trial of CDI-988 for the prophylaxis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback